摘要:
The present invention relates to pharmaceutical combinations comprising dual Angiopoietin-2 / Dll4 binders and anti-VEGF agents for use in treating diseases like cancer and ocular diseases.
摘要:
The present invention encompasses compounds of the general formula (1) in which R1 to R6, X and Y are each as defined in claim 1, which are suitable for treating disorders which are characterized by excessive or abnormal cell proliferation, and to their use for producing a medicament with the aforementioned properties.